Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Eli Lilly has offered to buy biopharmaceutical company ImClone, for $6.1 billion, or $70 a share topping Bristol-Myers Squibb's offer of $62 per share, reported Reuters.
Subscribe to our email newsletter
According to the news source, ImClone has refused to comment on the proposed deal but has divulged that it is in talks with a big pharma company.
ImClone had previously rebuffed a takeover offer from Bristol-Myers Squibb, which already owns a piece of Imclone.